Is classical stereotactic radiotherapy the optimal partner for immunotherapy?

Oncology (Williston Park). 2015 May;29(5):340, 347, 387.
No abstract available

MeSH terms

  • Combined Modality Therapy
  • Humans
  • Immunotherapy*
  • Neoplasms / therapy*
  • Radiosurgery*